title: Management of essential tremor.
abstract: Essential tremor (ET) is the most prevalent tremor syndrome. It commonly affects the hands, head, voice, and other body parts. Appropriate management begins with correct diagnosis. Primidone and propranolol are the first-line medications for the treatment for ET, but several other medications may also provide benefit. In patients with medically refractory tremor, alternative therapies, including surgery or injections of botulinum toxin, may be considered.
authors.affiliation: Parkinson's Disease and Movement Disorders Center and Department of Neurology, University of South Florida, Harborside Medical Tower, 4 Columbia Drive, Suite 410, Tampa, FL 33606, USA. tzesiewi@hsc.usf.edu
authors.forename: Theresa A
authors.initials: TA
authors.lastname: Zesiewicz
authors.forename: Elmyra
authors.initials: E
authors.lastname: Encarnacion
authors.forename: Robert A
authors.initials: RA
authors.lastname: Hauser
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004599:Electric Stimulation Therapy; D020329:Essential Tremor / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery / Q000628:therapy*; D006801:Humans; D008704:Methazolamide / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013788:Thalamus / Q000378:metabolism / Q000601:surgery
chemical_list: D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000927:Anticonvulsants; D001905:Botulinum Toxins; D002121:Calcium Channel Blockers; D002257:Carbonic Anhydrase Inhibitors; D008704:Methazolamide; D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors